The following Journal of Antimicrobial Chemotherapy supplements are currently available online:
- Aspects of Antimicrobial Resistance
- Journal of Antimicrobial Chemotherapy 2009 Sep; 64 (Suppl 1) : i1-i40.
- The changing face of febrile neutropenia-from monotherapy to moulds to mucositis
- Journal of Antimicrobial Chemotherapy 2009 May; 63 (Suppl 1) : i1-i43.
- Daptomycin development and clinical experience
- Journal of Antimicrobial Chemotherapy 2008 Nov; 62 (Suppl 3) : iii1-iii49.
- The British Society for Antimicrobial Chemotherapy Resistance Surveillance Project 1999/2000-2006/7
- Journal of Antimicrobial Chemotherapy 2008 Nov; 62 (Suppl 2) : ii1-ii114.
- Tigecycline, a therapeutic option from a new antimicrobial class (the glycylcyclines) in an era of increasing resistance
- Journal of Antimicrobial Chemotherapy 2008 Sep; 62 (Suppl 1) : i1-i40.
- Difficult issues in mycology
- Journal of Antimicrobial Chemotherapy 2008 Jan; 61 (Suppl 1) : i1-i44.
- Combating antimicrobial resistance: the role of the Specialist Advisory Committee on Antimicrobial Resistance, 2001-7
- Journal of Antimicrobial Chemotherapy 2007 Aug; 60 (Suppl 1) : i3-i90.
- Supplement S1 Antibiotic resistance--action to promote new technologies: report of an EU Intergovernmental Conference held in Birmingham, UK, 12-13 December 2005
- Journal of Antimicrobial Chemotherapy 2006 Sep; 58 (Suppl 1) : i1-i22.
- The Alexander Project: the benefits from a decade of surveillance
- Journal of Antimicrobial Chemotherapy 2005 Oct; 56 (Suppl 2) : ii1-ii21.
- Itraconazole and the management of systemic fungal infections
- Journal of Antimicrobial Chemotherapy 2005 Sep; 56 (Suppl 1) : i1-i54.
- Dalbavancin, a novel second-generation lipoglycopeptide agent for the treatment of serious Gram-positive infections
- Journal of Antimicrobial Chemotherapy 2005 Mar; 55 (Suppl 2) : ii1-ii35.
- Oseltamivir (Tamiflu®) and its potential for use in the event of an influenza pandemic
- Journal of Antimicrobial Chemotherapy 2005 Feb; 55 (Suppl 1) : i1-i21.
- PROTEKT US: results from the second year of this longitudinal surveillance study of antimicrobial resistance among respiratory tract pathogens isolated from paediatric and adult patients in the USA
- Journal of Antimicrobial Chemotherapy 2004 Aug; 54 (Suppl 1) : i1-i29.
- Treatment of complicated community-acquired infections with ertapenem, the first Group 1 carbapenem
- Journal of Antimicrobial Chemotherapy 2004 May; 53 (Suppl 2) : ii1-ii86.
- Augmentin® (amoxicillin/clavulanate) in the treatment of community-acquired respiratory tract infection: a review of the continuing development of an innovative antimicrobial agent
- Journal of Antimicrobial Chemotherapy 2004 Feb; 53 (Suppl 1) : i1-i20.
- Managing skin and soft tissue infections: expert panel recommendations on key decision points
- Journal of Antimicrobial Chemotherapy 2003 Nov; 52 (Suppl 1) : i1-i17.
- Vancomycin resistance in enterococci: a clinical challenge
- Journal of Antimicrobial Chemotherapy 2003 Jun; 51 (Suppl 3) : iii1-iii35.
- Linezolid: a novel oxazolidinone antimicrobial for the treatment of serious Gram-positive infections
- Journal of Antimicrobial Chemotherapy 2003 May; 51 (Suppl 2) : ii1-ii53.
- Antimicrobial development: quinolones past, present and future
- Journal of Antimicrobial Chemotherapy 2003 May; 51 (Suppl 1) : 1-47.
- Streptococcus pneumoniae: antimicrobials and ecology
- Journal of Antimicrobial Chemotherapy 2002 Dec; 50 (Suppl 3) : 1-100.
- PROTEKT: an innovative resistance surveillance programme for RTI pathogens
- Journal of Antimicrobial Chemotherapy 2002 Sep; 50 (Suppl 2) : 1-70.
- Cefpodoxime: fighting bacterial resistance
- Journal of Antimicrobial Chemotherapy 2002 Jul; 50 (Suppl 1) : 1-27.
- AmBisome: an international workshop
- Journal of Antimicrobial Chemotherapy 2002 Jan; 49 (Suppl 1) : 1-86.
- Structure and in vitro activity of telithromycin, the first member of a new class of antibacterials, the ketolides
- Journal of Antimicrobial Chemotherapy 2001 Sep; 48 (Topic 1) : 0-42.
- Antimicrobial Susceptibility Testing: BSAC Working Party Report
- Journal of Antimicrobial Chemotherapy 2001 Jul; 48 (Suppl 1) : 0-102.
- Abstracts of the 7th International Symposium on New Quinolones
- Journal of Antimicrobial Chemotherapy 2001 May; 47 (Suppl 1) : 3-50.
- Herpesvirus infections: not just skin deep
- Journal of Antimicrobial Chemotherapy 2001 Feb; 47 (Topic 1) : 0-34.
- Progress in the management of urinary tract infections
- Journal of Antimicrobial Chemotherapy 2000 Aug; 46 (Suppl 1) : 0-65.
- Global trends in resistance: initial results from the MYSTIC longitudinal surveillance programme
- Journal of Antimicrobial Chemotherapy 2000 Aug; 46 (Topic 2) : 0-58.
- Evolving quinolone therapy: focus on gemifloxacin
- Journal of Antimicrobial Chemotherapy 2000 Jul; 46 (Topic 1) : 1-37.
- Gemifloxacin:potency and performance
- Journal of Antimicrobial Chemotherapy 2000 Apr; 45 (Suppl 1) : 0-107.
- Recent advances in the management of herpesvirus infections
- Journal of Antimicrobial Chemotherapy 2000 Apr; 45 (Topic 3) : 0-43.
- Optimizing outcomes in the management of acute exacerbations of chronic bronchitis
- Journal of Antimicrobial Chemotherapy 2000 Mar; 45 (Topic 2) : 0-32.
- Tonsillopharyngitis revisited
- Journal of Antimicrobial Chemotherapy 2000 Feb; 45 (Topic 1) : 0-35.
- Zanamivir - a breakthrough in influenza
- Journal of Antimicrobial Chemotherapy 1999 Nov; 44 (Topic B) : 0-29.
- Quinupristin/dalfopristin - a novel approach for the treatment of serious Gram-positive infections
- Journal of Antimicrobial Chemotherapy 1999 Sep; 44 (Topic A) : 0-46.
- Levofloxacin: an extended spectrum 4-quinolone agent
- Journal of Antimicrobial Chemotherapy 1999 Jun; 43 (Suppl 3) : 0-90.
- Moxifloxacin: a new respiratory quinolone
- Journal of Antimicrobial Chemotherapy 1999 May; 43 (Suppl 2) : 0-100.
- Ten years of ciprofloxacin: the past, present and future
- Journal of Antimicrobial Chemotherapy 1999 Mar; 43 (Suppl 1) : 0-134.
- Infection in the neutropenic patient
- Journal of Antimicrobial Chemotherapy 1998 Jun; 41 (Suppl 4) : 0-105.
- Clostridium difficile infection
- Journal of Antimicrobial Chemotherapy 1998 May; 41 (Suppl 3) : 0-72.
- Roxithromycin - additional therapeutic potential
- Journal of Antimicrobial Chemotherapy 1998 Mar; 41 (Suppl 2) : 0-97.
- Sepsis
- Journal of Antimicrobial Chemotherapy 1998 Jan; 41 (Suppl 1) : 0-112.
- Grepafloxacin: focus on respiratory infections
- Journal of Antimicrobial Chemotherapy 1997 Dec; 40 (Suppl 1) : 0-101.
- The clinical evaluation of antiviral agents
- Journal of Antimicrobial Chemotherapy 1997 Dec; 40 (Suppl 2) : 1-67.
- Trovafloxacin: a novel extended spectrum quinolone
- Journal of Antimicrobial Chemotherapy 1997 Jun; 39 (Suppl 2) : 0-97.
- Quinupristin/dalfopristin - update on the first injectable streptogramin
- Journal of Antimicrobial Chemotherapy 1997 May; 39 (Suppl 1) : 0-151.